Developing a biomarker feedback intervention to motivate smoking cessation during pregnancy: Phase II MAW study

Kathryn R. Koller, Christie A. Flanagan, Gretchen E. Day, Timothy K. Thomas, Christina A. Smith, Abbie W. Wolfe, Crystal Meade, Christine A. Hughes, Vanessa Y. Hiratsuka, Neil J. Murphy, Christi Ann Patten

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: The prevalence of smoking during pregnancy for Alaska Native (AN) women is more than triple that of non-Native Alaska women. In this qualitative study, we solicited input from AN women and others to determine how best to present findings from an earlier study demonstrating a strong correlation between biomarkers for maternal smoking (cotinine) and neonatal exposure to a tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) to motivate cessation. Methods: We developed a brochure incorporating generalized biomarker information. Using indepth individual interviews with pregnant and postpartum AN women and partners/family members, we explored applicability and acceptability of the information. Postpartum women, who had participated in the earlier correlation study, additionally received their individual biomarker results. We assessed whether being presented general or individual biomarker information would motivate cessation using content analysis. Results: We conducted 39 interviews: 16 pregnant women, 12 postpartum women, and 11 partners/ family members. Overall, participants agreed the biomarker information was new, but understandable as presented. Postpartum women shared that learning their personal results inspired them to want to quit or cut back smoking while pregnant women indicated the generalized correlation information was less helpful in motivating cessation. Conclusion: Generalized information about fetal exposure to carcinogens may be more effective in motivating pregnant women to quit smoking when combined with individual cotinine testing. Implications: Using feedback from this study, we refined and are currently evaluating an intervention incorporating generalized correlation information from Phase I and cotinine testing to determine its effectiveness in motivating smoking cessation among pregnant AN women.

Original languageEnglish (US)
Pages (from-to)930-936
Number of pages7
JournalNicotine and Tobacco Research
Volume19
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Smoking Cessation
Cotinine
Biomarkers
Postpartum Period
Pregnancy
Smoking
Pregnant Women
Carcinogens
Interviews
Pamphlets
Tobacco
Mothers
Learning
Alaska Natives

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Developing a biomarker feedback intervention to motivate smoking cessation during pregnancy : Phase II MAW study. / Koller, Kathryn R.; Flanagan, Christie A.; Day, Gretchen E.; Thomas, Timothy K.; Smith, Christina A.; Wolfe, Abbie W.; Meade, Crystal; Hughes, Christine A.; Hiratsuka, Vanessa Y.; Murphy, Neil J.; Patten, Christi Ann.

In: Nicotine and Tobacco Research, Vol. 19, No. 8, 01.08.2017, p. 930-936.

Research output: Contribution to journalArticle

Koller, KR, Flanagan, CA, Day, GE, Thomas, TK, Smith, CA, Wolfe, AW, Meade, C, Hughes, CA, Hiratsuka, VY, Murphy, NJ & Patten, CA 2017, 'Developing a biomarker feedback intervention to motivate smoking cessation during pregnancy: Phase II MAW study', Nicotine and Tobacco Research, vol. 19, no. 8, pp. 930-936. https://doi.org/10.1093/ntr/ntw330
Koller, Kathryn R. ; Flanagan, Christie A. ; Day, Gretchen E. ; Thomas, Timothy K. ; Smith, Christina A. ; Wolfe, Abbie W. ; Meade, Crystal ; Hughes, Christine A. ; Hiratsuka, Vanessa Y. ; Murphy, Neil J. ; Patten, Christi Ann. / Developing a biomarker feedback intervention to motivate smoking cessation during pregnancy : Phase II MAW study. In: Nicotine and Tobacco Research. 2017 ; Vol. 19, No. 8. pp. 930-936.
@article{792627b46d9747be95c6032ad15a8296,
title = "Developing a biomarker feedback intervention to motivate smoking cessation during pregnancy: Phase II MAW study",
abstract = "Introduction: The prevalence of smoking during pregnancy for Alaska Native (AN) women is more than triple that of non-Native Alaska women. In this qualitative study, we solicited input from AN women and others to determine how best to present findings from an earlier study demonstrating a strong correlation between biomarkers for maternal smoking (cotinine) and neonatal exposure to a tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) to motivate cessation. Methods: We developed a brochure incorporating generalized biomarker information. Using indepth individual interviews with pregnant and postpartum AN women and partners/family members, we explored applicability and acceptability of the information. Postpartum women, who had participated in the earlier correlation study, additionally received their individual biomarker results. We assessed whether being presented general or individual biomarker information would motivate cessation using content analysis. Results: We conducted 39 interviews: 16 pregnant women, 12 postpartum women, and 11 partners/ family members. Overall, participants agreed the biomarker information was new, but understandable as presented. Postpartum women shared that learning their personal results inspired them to want to quit or cut back smoking while pregnant women indicated the generalized correlation information was less helpful in motivating cessation. Conclusion: Generalized information about fetal exposure to carcinogens may be more effective in motivating pregnant women to quit smoking when combined with individual cotinine testing. Implications: Using feedback from this study, we refined and are currently evaluating an intervention incorporating generalized correlation information from Phase I and cotinine testing to determine its effectiveness in motivating smoking cessation among pregnant AN women.",
author = "Koller, {Kathryn R.} and Flanagan, {Christie A.} and Day, {Gretchen E.} and Thomas, {Timothy K.} and Smith, {Christina A.} and Wolfe, {Abbie W.} and Crystal Meade and Hughes, {Christine A.} and Hiratsuka, {Vanessa Y.} and Murphy, {Neil J.} and Patten, {Christi Ann}",
year = "2017",
month = "8",
day = "1",
doi = "10.1093/ntr/ntw330",
language = "English (US)",
volume = "19",
pages = "930--936",
journal = "Nicotine and Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Developing a biomarker feedback intervention to motivate smoking cessation during pregnancy

T2 - Phase II MAW study

AU - Koller, Kathryn R.

AU - Flanagan, Christie A.

AU - Day, Gretchen E.

AU - Thomas, Timothy K.

AU - Smith, Christina A.

AU - Wolfe, Abbie W.

AU - Meade, Crystal

AU - Hughes, Christine A.

AU - Hiratsuka, Vanessa Y.

AU - Murphy, Neil J.

AU - Patten, Christi Ann

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Introduction: The prevalence of smoking during pregnancy for Alaska Native (AN) women is more than triple that of non-Native Alaska women. In this qualitative study, we solicited input from AN women and others to determine how best to present findings from an earlier study demonstrating a strong correlation between biomarkers for maternal smoking (cotinine) and neonatal exposure to a tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) to motivate cessation. Methods: We developed a brochure incorporating generalized biomarker information. Using indepth individual interviews with pregnant and postpartum AN women and partners/family members, we explored applicability and acceptability of the information. Postpartum women, who had participated in the earlier correlation study, additionally received their individual biomarker results. We assessed whether being presented general or individual biomarker information would motivate cessation using content analysis. Results: We conducted 39 interviews: 16 pregnant women, 12 postpartum women, and 11 partners/ family members. Overall, participants agreed the biomarker information was new, but understandable as presented. Postpartum women shared that learning their personal results inspired them to want to quit or cut back smoking while pregnant women indicated the generalized correlation information was less helpful in motivating cessation. Conclusion: Generalized information about fetal exposure to carcinogens may be more effective in motivating pregnant women to quit smoking when combined with individual cotinine testing. Implications: Using feedback from this study, we refined and are currently evaluating an intervention incorporating generalized correlation information from Phase I and cotinine testing to determine its effectiveness in motivating smoking cessation among pregnant AN women.

AB - Introduction: The prevalence of smoking during pregnancy for Alaska Native (AN) women is more than triple that of non-Native Alaska women. In this qualitative study, we solicited input from AN women and others to determine how best to present findings from an earlier study demonstrating a strong correlation between biomarkers for maternal smoking (cotinine) and neonatal exposure to a tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) to motivate cessation. Methods: We developed a brochure incorporating generalized biomarker information. Using indepth individual interviews with pregnant and postpartum AN women and partners/family members, we explored applicability and acceptability of the information. Postpartum women, who had participated in the earlier correlation study, additionally received their individual biomarker results. We assessed whether being presented general or individual biomarker information would motivate cessation using content analysis. Results: We conducted 39 interviews: 16 pregnant women, 12 postpartum women, and 11 partners/ family members. Overall, participants agreed the biomarker information was new, but understandable as presented. Postpartum women shared that learning their personal results inspired them to want to quit or cut back smoking while pregnant women indicated the generalized correlation information was less helpful in motivating cessation. Conclusion: Generalized information about fetal exposure to carcinogens may be more effective in motivating pregnant women to quit smoking when combined with individual cotinine testing. Implications: Using feedback from this study, we refined and are currently evaluating an intervention incorporating generalized correlation information from Phase I and cotinine testing to determine its effectiveness in motivating smoking cessation among pregnant AN women.

UR - http://www.scopus.com/inward/record.url?scp=85026463395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026463395&partnerID=8YFLogxK

U2 - 10.1093/ntr/ntw330

DO - 10.1093/ntr/ntw330

M3 - Article

C2 - 28003506

AN - SCOPUS:85026463395

VL - 19

SP - 930

EP - 936

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - 8

ER -